FDA Inspection 1059272 — Diamond Institute For Infertility And Menopause
The FDA completed an inspection of Diamond Institute For Infertility And Menopause on Jul 6, 2018 in Millburn, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 6, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Millburn, NJ (United States)